3-HYDROXY-2-(4-METHOXYPHENYL)-2,3-DIHYDRO-1,5-BENZOTHIAZEPIN-4(5H)-ONE, (2S,3S)-
UNII 6RN4N3305M
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5h)-one, (2s,3s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6RN4N3305M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 42399-49-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H15NO3S LHBHZALHFIQJGJ-CABCVRRESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5h)-one, (2s,3s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.